| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 95.351 | 45.099 | 21.307 | 3.699 | - | - | - | - | - | - |
| Total Income - EUR | 100.419 | 48.526 | 35.982 | 3.746 | - | - | - | - | - | - |
| Total Expenses - EUR | 92.465 | 62.068 | 47.543 | 13.339 | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 7.954 | -13.542 | -11.561 | -9.594 | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 7.954 | -13.542 | -11.561 | -9.651 | - | - | - | - | - | - |
| Employees | 2 | 2 | 1 | 1 | - | - | - | - | - | - |
Check the financial reports for the company - Hospitex Diagnostics S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.425 | 8.939 | 96 | 60 | - | - | - | - | - | - |
| Current Assets | 49.527 | 38.948 | 34.926 | 35.121 | - | - | - | - | - | - |
| Inventories | 29.389 | 19.295 | 687 | 1.816 | - | - | - | - | - | - |
| Receivables | 18.520 | 16.175 | 31.937 | 33.261 | - | - | - | - | - | - |
| Cash | 1.618 | 3.478 | 2.302 | 44 | - | - | - | - | - | - |
| Shareholders Funds | -57.782 | -70.736 | -81.100 | -89.262 | - | - | - | - | - | - |
| Social Capital | 34.646 | 34.292 | 33.712 | 33.093 | - | - | - | - | - | - |
| Debts | 120.734 | 118.690 | 116.183 | 124.503 | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Hospitex Diagnostics S.r.l.